Autonomix Medical, Inc. Common Stock
$4.28
$0.16 (+3.88%)
$4.05Day Range$4.38
Key Statistics
Market Cap
$8.39M
Shares Outstanding
2.0M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jan 29, 2024
Round Lot
100
Locale
US
Trading Data
Day Open
$4.05
Day High
$4.38
Day Low
$4.05
Volume
67.4K
VWAP
$4.23
Prev Close
$4.12
Transactions
--
Acc. Volume
--
About Autonomix Medical, Inc. Common Stock
Autonomix Medical Inc is a development-stage medical device company focused on advancing technologies for sensing and treating disorders of the nervous system. Its platform is designed to integrate high-sensitivity neural signal detection with targeted radiofrequency (RF) ablation, enabling a sense, treat, verify approach for nerve-targeted therapies. The Company operates in one reportable segment, which is advancing the development of technologies for sensing and treating disorders relating to the nervous system. It is initially focused on developing the technology for patients with pancreatic cancer and believes the technology has the potential to address several indications, including chronic pain management, hypertension, cardiovascular disease, and other nerve-related disorders.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSSIC 384111 employees21 WATERWAY AVENUE, SUITE 300, THE WOODLANDS, TX, 77380832-277-7816IPO Jan 29, 2024US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001617867
- Composite FIGI
- BBG00R28GXW5
- Share Class FIGI
- BBG00R28GXX4
- Ticker Root
- AMIX
- SIC Code
- 3841
About Autonomix Medical, Inc. Common Stock (AMIX) Stock
Autonomix Medical, Inc. Common Stock (AMIX) closed the 2026-09-17 session at $4.28, up 3.88% versus the previous close (+0.16). The stock opened at $4.05 and traded between $4.05 and $4.38 during that session. Session trading volume was 67K shares. The volume-weighted average price (VWAP) is $4.23.
Autonomix Medical Inc is a development-stage medical device company focused on advancing technologies for sensing and treating disorders of the nervous system. Its platform is designed to integrate high-sensitivity neural signal detection with targeted radiofrequency (RF) ablation, enabling a sense, treat, verify approach for nerve-targeted therapies. The Company operates in one reportable segment, which is advancing the development of technologies for sensing and treating disorders relating to the nervous system. It is initially focused on developing the technology for patients with pancreatic cancer and believes the technology has the potential to address several indications, including chronic pain management, hypertension, cardiovascular disease, and other nerve-related disorders.
Autonomix Medical, Inc. Common Stock has a market capitalization of $8.4 million. The company operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry classification. AMIX is listed on the XNAS exchange. The company employs approximately 11 people. Autonomix Medical, Inc. Common Stock is headquartered in THE WOODLANDS, TX. The recorded listing date is 2024-01-29.
On this page you can find market AMIX stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.